8/29/2014

The Southern California Permanente Medical Group has agreed to work with Pacific Edge to investigate the latter's Cxbladder test. The assay is used to rule out bladder cancer in patients by quantifying the levels of gene expression for five biomarkers linked to the illness.

Related Summaries